US 12173306
Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders
granted A61KA61K33/34A61K38/46
Quick answer
US patent 12173306 (Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K33/34, A61K38/46, A61K48/005, A61P